Overview
Title
To reauthorize certain programs that provide for opioid use disorder prevention, treatment, and recovery, and for other purposes.
ELI5 AI
H.R. 2483 is a plan to help people in the U.S. with problems from using drugs like opioids. It tries to stop overdoses, gives help to new moms, trains helpers like police, and teaches about dangers such as fentanyl, all while handling money wisely.
Summary AI
H.R. 2483 is a bill to update and continue various programs related to preventing and treating opioid use disorder in the United States. It focuses on initiatives like improving prenatal and postnatal health, preventing overdoses, providing training for first responders, and supporting individuals with fetal alcohol spectrum disorder. The bill also aims to increase funding for addiction treatment and recovery support, enhance cybersecurity for suicide prevention hotlines, and promote educational outreach to raise awareness about opioid risks, including the dangers of fentanyl. Additionally, it proposes measures to improve the mental health care system, including guidance for treating serious mental illness and supporting community recovery efforts.
Published
Keywords AI
Sources
Bill Statistics
Size
Language
Complexity
AnalysisAI
Summary of the Bill
The bill, titled "SUPPORT for Patients and Communities Reauthorization Act of 2025," aims to renew and enhance programs related to opioid use disorder prevention, treatment, and recovery in the United States. It is a comprehensive legislative effort that addresses a broad range of opioid-related issues, aiming to provide ongoing support and develop innovative approaches to combat the opioid crisis. The bill covers numerous provisions, including prevention strategies, treatment options, recovery support systems, and other miscellaneous concerns, such as training for prescribers of controlled substances.
Summary of Significant Issues
Several issues arise within the various sections of the bill. One major concern is the significant increase in funding for some programs, such as the "Building communities of recovery" initiative, which raises from $5,000,000 to $17,000,000 per fiscal year. Similar concerns appear in sections like "Preventing overdoses of controlled substances," which see a substantial funding boost from $496,000,000 to $505,579,000 without specific accountability measures or detailed justification for how the funds will be used.
Additionally, certain amendments, such as those in "Bruce’s law," introduce strategies to educate on synthetic opioids but lack clarity on their implementation, potentially leading to ineffective outreach efforts. The "Loan repayment program for substance use disorder treatment workforce" and "Mental and behavioral health training grants" also experience funding increases without corresponding details on utilization, creating transparency and accountability issues.
Another notable area for concern is the language used in some sections, such as in "Delivery of a controlled substance by a pharmacy to a prescribing practitioner." The text is complex and may introduce legal and implementation challenges without adequate clarification.
Impact on the Public
Broadly, the bill aims to positively impact the public by addressing the ongoing opioid crisis, which affects millions across the country. By reauthorizing and increasing funding for programs dedicated to preventing and treating opioid addiction, as well as supporting recovery, the bill has the potential to provide significant benefits to individuals and families affected by opioid use disorders. Enhanced training and education provisions could lead to a more informed public and healthcare community, ideally reducing the stigma associated with substance use disorders and increasing access to relevant resources.
Impact on Specific Stakeholders
For healthcare providers and first responders, the bill's enhanced training programs and increased funding for first responder initiatives could enhance their ability to provide critical interventions and support. However, without specific guidelines, there may be challenges regarding consistency and the effective implementation of programs across different regions.
For organizations working in opioid addiction recovery and prevention, the increased funding provides an opportunity to expand services and reach larger populations. Nevertheless, the lack of detailed criteria for funding allocation and program evaluation could result in ineffective use or favoritism in fund distribution, potentially hindering service delivery.
Individuals and families directly impacted by the opioid crisis may benefit from funded recovery programs and improved access to care. However, the effectiveness of these benefits relies heavily on the bill's implementation and oversight measures, which need clarity and thorough evaluation methods to ensure that resources are utilized efficiently.
Overall, while the bill sets out to address critical needs in combating the opioid crisis, its success will depend largely on how well implementation challenges are managed and how effectively funds are allocated and monitored to avoid wasteful spending. Stakeholders and policymakers will need to address these issues to fully realize the potential benefits of the legislative measures.
Financial Assessment
The bill, H.R. 2483, involves various financial allocations to continue and update programs related to opioid use disorder. Several notable expenditures and appropriations are highlighted within the bill.
Financial Allocations Overview
Section 101: Prenatal and Postnatal Health - The bill allocates $4,250,000 annually for prenatal and postnatal health initiatives, intended to support maternal health from fiscal years 2026 through 2030.
Section 103: Preventing Overdoses of Controlled Substances - There is an appropriation of $505,579,000 annually for efforts to prevent overdoses. This is an increase from a previous allocation of $496,000,000 and is intended to support innovative projects that include strategies like wastewater surveillance for detecting substance misuse.
Section 106: First Responder Training Program - Funding for this program is significantly increased to $57,000,000 annually from the previous $36,000,000, aimed at improving the readiness of first responders for overdose situations.
Section 107: Donald J. Cohen National Child Traumatic Stress Initiative - The initiative receives a considerable financial commitment, with a range of $98,887,000 to $100,000,000 annually from 2026 to 2030, aimed at supporting trauma resources and training.
Section 109: Monitoring and Reporting of Child, Youth, and Adult Trauma - Funding is substantially raised to $9,000,000 annually, from the previous $2,000,000, to enhance the monitoring and reporting capabilities related to trauma.
Section 204: Loan Repayment Program for Substance Use Disorder Treatment Workforce - This program sees its funding rise to $40,000,000 annually, from $25,000,000, aiming to strengthen the workforce for substance use disorder treatment.
Section 301: Building Communities of Recovery - The bill boosts the program's funding to $17,000,000 annually, up from $5,000,000, supporting recovery community efforts.
Relation to Identified Issues
Several issues concerning these financial allocations have been identified:
- Lack of Transparency and Justification:
The substantial increase in funding for programs like Building Communities of Recovery and Preventing Overdoses raises questions about the specifics of how these funds will be allocated and utilized. The bill does not detail the intended use of increased funds, leading to concerns about transparency and accountability.
Justification for Increased Spending:
Programs like the First Responder Training Program and Preventing Overdoses see notable budget increases without corresponding explanations or evaluations of expected outcomes, which could lead to potential misuse or wasteful spending.
Guidelines and Criteria:
- The increase for the Loan Repayment Program lacks detailed criteria or guidelines for fund distribution, which could hinder transparency and effectiveness in addressing workforce needs.
Prenatal and Postnatal Health funding, while fixed annually, lacks clarity on fund distribution and evaluation methods, risking inefficiency.
Complex Language and Implementation:
Sections such as the Delivery of a Controlled Substance amendment have intricate language that lacks clarity, potentially complicating enforcement and raising implementation challenges.
Undefined Standards:
- Criteria for "evidence-based treatments" and "standard of care" in Section 208 are not explicitly defined, potentially leading to uneven care standards across states, affecting budget allocation efficiency.
The financial references throughout the bill highlight an emphasis on robust funding for substance use disorder-related programs while simultaneously suggesting potential areas of concern regarding the utilization and accountability of these funds.
Issues
The substantial funding increase for the 'Building communities of recovery' program (Sec. 301) from $5,000,000 to $17,000,000 per fiscal year raises concerns about justification and accountability. The bill text does not specify how the increased funds will be utilized, leading to potential transparency and allocation issues.
The significant increase in appropriations for 'Preventing overdoses of controlled substances' (Sec. 103) from $496,000,000 to $505,579,000 needs clear justification, especially in light of the need to ensure effective allocation and prevent wasteful spending.
The increase in funding for the 'First responder training program' from $36,000,000 to $57,000,000 per fiscal year (Sec. 106) appears excessive without corresponding justification or evaluations of projected outcomes, raising concerns about potential waste.
The amendment to 'Bruce’s law' (Sec. 110) introduces broad strategies to increase education on synthetic opioids but lacks specific implementation details, which could lead to vague accountability and ineffective outreach efforts.
The lack of transparency in the funding allocation for 'Prenatal and postnatal health' (Sec. 101), with fixed annual allocations of $4,250,000, raises concerns about how funds will be disbursed and evaluated for effectiveness.
The 'Loan repayment program for substance use disorder treatment workforce' (Sec. 204) receives a funding increase from $25 million to $40 million annually. Without detailed specification of criteria or guidelines for the distribution, this leads to transparency and accountability concerns.
The amendments concerning 'Delivery of a controlled substance by a pharmacy to a prescribing practitioner' (Sec. 401) have complex language and do not clarify enforcement or funding, which could raise legal and implementation challenges.
The bill mandates increased appropriations for mental and behavioral health training grants (Sec. 203) without specifying expected outcomes or measures of success, raising concerns about spending oversight and effectiveness.
The 'State guidance related to individuals with serious mental illness and children with serious emotional disturbance' section (Sec. 208) lacks specific criteria for ‘evidence-based treatments’ and 'standard of care,' potentially leading to inconsistencies and variations in care across states.
Sections
Sections are presented as they are annotated in the original legislative text. Any missing headers, numbers, or non-consecutive order is due to the original text.
1. Short title; table of contents Read Opens in new tab
Summary AI
The “SUPPORT for Patients and Communities Reauthorization Act of 2025” introduces measures for preventing and treating substance use disorders, promoting recovery, and managing miscellaneous matters related to controlled substances. It includes sections focusing on health education, treatment programs for expectant mothers, community recovery efforts, and necessary regulations for controlled substances.
101. Prenatal and postnatal health Read Opens in new tab
Summary AI
The given section of the Public Health Service Act changes how much money can be spent on prenatal and postnatal health programs. It updates the funding from an unspecified amount for the years 2019 to 2023 to a set amount of $4,250,000 for each year from 2026 to 2030.
Money References
- Section 317L(d) of the Public Health Service Act (42 U.S.C. 247b–13(d)) is amended by striking “such sums as may be necessary for each of the fiscal years 2019 through 2023” and inserting “$4,250,000 for each of fiscal years 2026 through 2030”.
102. Monitoring and education regarding infections associated with illicit drug use and other risk factors Read Opens in new tab
Summary AI
The bill changes the dates in a section of the Public Health Service Act, so that the monitoring and education about infections related to drug use and other risks will continue from 2026 to 2030 instead of ending in 2023.
103. Preventing overdoses of controlled substances Read Opens in new tab
Summary AI
The bill proposes changes to the Public Health Service Act to enhance efforts in preventing overdoses from controlled substances. It involves amending sections related to identifying, monitoring, and responding to substance misuse and associated risks, providing additional grants for innovative projects, and adjusting funding amounts for the years 2026 through 2030.
Money References
- Such projects may include the use of innovative, evidence-based strategies for detecting such patterns, such as wastewater surveillance, if proven to support actionable prevention strategies, in a manner consistent with applicable Federal and State privacy laws.”; and (3) in subparagraph (B), by striking “for any” and inserting “For any”. (c) Authorization of appropriations.—Section 392A(e) of the Public Health Service Act (42 U.S.C. 280b–1(e)) is amended by striking “$496,000,000 for each of fiscal years 2019 through 2023” and inserting “$505,579,000 for each of fiscal years 2026 through 2030”.
104. Support for individuals and families impacted by fetal alcohol spectrum disorder Read Opens in new tab
Summary AI
The section amends the Public Health Service Act to strengthen efforts to prevent and address fetal alcohol spectrum disorders (FASD). It establishes programs for education, public awareness, research, and support via grants and technical assistance to eligible entities, and authorizes $12.5 million annually for these initiatives from 2026 to 2030.
Money References
- “There are authorized to be appropriated to carry out this part $12,500,000 for each of fiscal years 2026 through 2030.”.
399H. Fetal alcohol spectrum disorders prevention, intervention, and services delivery program Read Opens in new tab
Summary AI
The section outlines a program by the Secretary to support education, prevention, identification, and intervention services for fetal alcohol spectrum disorders (FASD). It involves public awareness initiatives, research, and support for State and Tribal capacity to help affected individuals and families. It also allows for grants and technical assistance to eligible entities, such as States and nonprofit organizations, which meet certain requirements.
399I. Strengthening capacity and education for fetal alcohol spectrum disorders Read Opens in new tab
Summary AI
The Secretary of Health is authorized to give grants or contracts to organizations with expertise in fetal alcohol spectrum disorders (FASD) to help prevent these disorders. This includes developing educational programs, providing resources and training, and supporting effective tools and services for dealing with FASD. Organizations can partner with others to carry out these tasks.
399J. Authorization of appropriations Read Opens in new tab
Summary AI
Congress has approved a budget of $12,500,000 each year from 2026 to 2030 to fund this section of the bill.
Money References
- There are authorized to be appropriated to carry out this part $12,500,000 for each of fiscal years 2026 through 2030.
105. Promoting state choice in PDMP systems Read Opens in new tab
Summary AI
The amendment to the Public Health Service Act ensures that states have the freedom to choose their own systems for prescription drug monitoring programs (PDMP) without being required to use specific vendors or connections, as long as they meet nationally recognized open standards.
106. First responder training program Read Opens in new tab
Summary AI
The section amends the Public Health Service Act to update wording related to drug terminology and funding. It specifies changes in how "opioid" is referenced, updates the text to include broader drug categories, and increases the allocated budget to $57,000,000 for fiscal years 2026 through 2030.
Money References
- Section 546 of the Public Health Service Act (42 U.S.C. 290ee–1) is amended— (1) in subsection (a), by striking “tribes and tribal” and inserting “Tribes and Tribal”; (2) in subsections (a), (c), and (d)— (A) by striking “approved or cleared” each place it appears and inserting “approved, cleared, or otherwise legally marketed”; and (B) by striking “opioid” each place it appears; (3) in subsection (f)— (A) by striking “approved or cleared” each place it appears and inserting “approved, cleared, or otherwise legally marketed”; (B) in paragraph (1), by striking “opioid”; (C) in paragraph (2)— (i) by striking “opioid and heroin” and inserting “opioid, heroin, and other drug”; and (ii) by striking “opioid overdose” and inserting “overdose”; and (D) in paragraph (3), by striking “opioid and heroin”; and (4) in subsection (h), by striking “$36,000,000 for each of fiscal years 2019 through 2023” and inserting “$57,000,000 for each of fiscal years 2026 through 2030”.
107. Donald J. Cohen National Child Traumatic Stress Initiative Read Opens in new tab
Summary AI
The section amends the Public Health Service Act to enhance the National Child Traumatic Stress Initiative by renaming parts and sections, expanding support for evidence-based practices related to traumatic events, and clarifying the roles of NCTSI grantees and the coordinating center. It also updates requirements for grant applications and authorizes specific funding amounts for fiscal years 2026 through 2030.
Money References
- GRANTEES.—NCTSI grantees shall, as appropriate, collaborate with other such grantees, the NCTSI coordinating center, and the Secretary in carrying out subsections (a)(2) and (d)(2).”; (6) by amending subsection (h) to read as follows: “(h) Application and evaluation.—To be eligible to receive a grant, contract, or cooperative agreement under subsection (a), a public or nonprofit private entity or an Indian Tribe or Tribal organization shall submit to the Secretary an application at such time, in such manner, and containing such information and assurances as the Secretary may require, including— “(1) a plan for the evaluation of the activities funded under the grant, contract, or agreement, including both process and outcomes evaluation, and the submission of an evaluation at the end of the project period; and “(2) a description of how such entity, Indian Tribe, or Tribal organization will support efforts led by the Secretary or the NCTSI coordinating center, as applicable, to evaluate activities carried out under this section.”; and (7) by amending subsection (j) to read as follows: “(j) Authorization of appropriations.—There is authorized to be appropriated to carry out this section— “(1) $98,887,000 for fiscal year 2026; “(2) $98,887,000 for fiscal year 2027; “(3) $98,887,000 for fiscal year 2028; “(4) $100,000,000 for fiscal year 2029; and “(5) $100,000,000 for fiscal year 2030.”.
108. Protecting suicide prevention lifeline from cybersecurity incidents Read Opens in new tab
Summary AI
Section 108 of the bill aims to protect the National Suicide Prevention Lifeline from cybersecurity incidents by requiring updated measures to secure the hotline from vulnerabilities. It mandates that network administrators and crisis centers report any identified cybersecurity risks or incidents promptly, ensures proper oversight of technology, and demands a study to evaluate these cybersecurity risks and vulnerabilities associated with the 9–8–8 National Suicide Prevention Lifeline.
109. Monitoring and reporting of child, youth, and adult trauma Read Opens in new tab
Summary AI
The amended section of the SUPPORT for Patients and Communities Act increases the funding for monitoring and reporting trauma-related issues in children, youth, and adults from $2,000,000 to $9,000,000 annually for the fiscal years 2026 through 2030.
Money References
- Section 7131(e) of the SUPPORT for Patients and Communities Act (42 U.S.C. 242t(e)) is amended by striking “$2,000,000 for each of fiscal years 2019 through 2023” and inserting “$9,000,000 for each of fiscal years 2026 through 2030”.
110. Bruce’s law Read Opens in new tab
Summary AI
Bruce’s Law aims to increase awareness and education about the dangers of synthetic opioids, such as fentanyl, by modifying existing acts. It forms a federal working group to address fentanyl contamination in illegal drugs and enhance responses to prevent overdoses, especially among youth, with annual reports and recommendations to Congress.
111. Guidance on at-home drug disposal systems Read Opens in new tab
Summary AI
The section requires the Secretary of Health and Human Services, alongside the Drug Enforcement Administration, to publish guidance within one year to help people use at-home drug disposal systems safely. This guidance will include recommended standards, usage instructions, best practices, educational tools, and advice on involving licensed health providers in the process.
112. Assessment of opioid drugs and actions Read Opens in new tab
Summary AI
The Secretary of Health and Human Services must publish a report about opioid drugs within a year, focusing on their safety, effectiveness, and impact on public health. This report will also discuss actions the FDA has taken or plans to take regarding opioid painkillers and the development of non-addictive pain treatments, and it will include public input on these issues.
113. Grant program for State and Tribal response to opioid use disorders Read Opens in new tab
Summary AI
The section describes a part of a grant program allowing states and tribes to enhance their response to opioid use disorders by possibly including tools like test strips to detect substances such as fentanyl, in accordance with existing laws.
201. Residential treatment program for pregnant and postpartum women Read Opens in new tab
Summary AI
The amendment to Section 508 of the Public Health Service Act enhances the care for pregnant and postpartum women by clarifying the need for health care services, requiring applicants to present a plan for service provision, and increasing the authorized funding to $38,931,000 annually for fiscal years 2026 through 2030.
Money References
- Section 508 of the Public Health Service Act (42 U.S.C. 290bb–1) is amended— (1) in subsection (d)(11)(C), by striking “providing health services” and inserting “providing health care services”; (2) in subsection (g)— (A) by inserting “a plan describing” after “will provide”; and (B) by adding at the end the following: “Such plan may include a description of how such applicant will target outreach to women disproportionately impacted by maternal substance use disorder.”; and (3) in subsection (s), by striking “$29,931,000 for each of fiscal years 2019 through 2023” and inserting “$38,931,000 for each of fiscal years 2026 through 2030”.
202. Improving access to addiction medicine providers Read Opens in new tab
Summary AI
Section 202 of the law modifies the Public Health Service Act by mandating the inclusion of “diagnosis” in the list of services related to addiction medicine, and it adds “addiction medicine” to fields recognized alongside psychiatry for better access to providers.
203. Mental and behavioral health education and training grants Read Opens in new tab
Summary AI
The section 203 of the bill amends the Public Health Service Act to change the timeframe for mental and behavioral health education and training grants from the fiscal years 2023-2027 to the fiscal years 2026-2030.
204. Loan repayment program for substance use disorder treatment workforce Read Opens in new tab
Summary AI
The section amends the Public Health Service Act to increase the funding for the loan repayment program for the substance use disorder treatment workforce from $25 million to $40 million for each year from 2026 to 2030.
Money References
- Section 781(j) of the Public Health Service Act (42 U.S.C. 295h(j)) is amended by striking “$25,000,000 for each of fiscal years 2019 through 2023” and inserting “$40,000,000 for each of fiscal years 2026 through 2030”.
205. Development and dissemination of model training programs for substance use disorder patient records Read Opens in new tab
Summary AI
The section amends the SUPPORT for Patients and Communities Act by removing subsection (e) from Section 7053, which deals with model training programs for managing records of patients with substance use disorders.
206. Task force on best practices for trauma-informed identification, referral, and support Read Opens in new tab
Summary AI
The amendments to Section 7132 of the SUPPORT for Patients and Communities Act involve adding the Administration for Community Living to the list, including developmental disability service providers, and extending a date in subsection (i) from 2023 to 2030.
207. Grants to enhance access to substance use disorder treatment Read Opens in new tab
Summary AI
The bill is making changes to a section of a law related to substance use disorder treatment. It is removing part of the existing text, eliminating subsection (b), and simplifying the starting phrase to just “The Secretary.”
208. State guidance related to individuals with serious mental illness and children with serious emotional disturbance Read Opens in new tab
Summary AI
The section mandates that the Secretary of Health and Human Services reviews how states use specific federal funds for early intervention in mental health issues, focusing on evidence-based treatments for individuals with serious mental illness and children with emotional disturbances. Based on this review, the Secretary must submit a report to Congress and later update guidance to improve mental health care services.
209. Reviewing the scheduling of approved products containing a combination of buprenorphine and naloxone Read Opens in new tab
Summary AI
The Secretary of Health and Human Services is instructed to review data related to the categorization of drugs that combine buprenorphine and naloxone, and may suggest changes to their classification. The Attorney General then decides whether to update their legal status based on this suggestion.
301. Building communities of recovery Read Opens in new tab
Summary AI
The bill amends the Public Health Service Act to increase funding for building communities of recovery from $5 million to $17 million for each fiscal year from 2026 to 2030.
Money References
- Section 547(f) of the Public Health Service Act (42 U.S.C. 290ee–2(f)) is amended by striking “$5,000,000 for each of fiscal years 2019 through 2023” and inserting “$17,000,000 for each of fiscal years 2026 through 2030”.
302. Peer support technical assistance center Read Opens in new tab
Summary AI
The amendments to Section 547A of the Public Health Service Act involve several changes, including the introduction of regional technical assistance centers to help support peer recovery services tailored to specific regions, with an evaluation of their effectiveness due by 2029. The section also increases funding from $1,000,000 to $2,000,000 annually for fiscal years 2026 through 2030.
Money References
- “(3) TERMINATION.—This subsection shall terminate on September 30, 2030.”; and (4) in subsection (f), as so redesignated, by striking “$1,000,000 for each of fiscal years 2019 through 2023” and inserting “$2,000,000 for each of fiscal years 2026 through 2030”.
303. Comprehensive opioid recovery centers Read Opens in new tab
Summary AI
The section updates the Public Health Service Act regarding opioid recovery centers by changing application requirements to include more details and documentation, revising reporting requirements for certain entities, and extending the program's funding period from 2026 to 2030.
304. Youth prevention and recovery Read Opens in new tab
Summary AI
The section updates the SUPPORT for Patients and Communities Act to change terms like "high schools" to "secondary schools" and ensures consistent use of "Tribe" and "Tribal" when referring to Native American groups. It extends the funding timeline through 2030 and increases the budget for programs that support youth at higher risk of substance misuse.
Money References
- SCHOOL.—The term ‘secondary school’ has the meaning given such term in section 8101 of the Elementary and Secondary Education Act of 1965 (20 U.S.C. 7801).”; (2) in paragraph (3)(A), in the matter preceding clause (i)— (A) by striking “and abuse”; and (B) by inserting “at increased risk for substance misuse” after “specific populations”; (3) in paragraph (4)— (A) in the matter preceding subparagraph (A), by striking “Indian tribes” and inserting “Indian Tribes”; (B) in subparagraph (A), by striking “and abuse”; and (C) in subparagraph (B), by striking “peer mentoring” and inserting “peer-to-peer support”; (4) in paragraph (5), by striking “tribal” and inserting “Tribal”; (5) in paragraph (6)(A)— (A) in clause (iv), by striking “; and” and inserting a semicolon; and (B) by adding at the end the following: “(vi) a plan to sustain the activities carried out under the grant program, after the grant program has ended; and”; (6) in paragraph (8), by striking “2022” and inserting “2028”; and (7) by amending paragraph (9) to read as follows: “(9) AUTHORIZATION OF APPROPRIATIONS.—To carry out this subsection, there are authorized to be appropriated— “(A) $10,000,000 for fiscal year 2026; “(B) $12,000,000 for fiscal year 2027; “(C) $13,000,000 for fiscal year 2028; “(D) $14,000,000 for fiscal year 2029; and “(E) $15,000,000 for fiscal year 2030.”.
305. CAREER Act Read Opens in new tab
Summary AI
The amendments to the CAREER Act within the SUPPORT for Patients and Communities Act expand the scope of grants for treatment, recovery, and workforce support, allowing a portion to be used for transportation related to job training and recovery activities. It also extends programs such as the Recovery Housing Pilot Program through 2030, updates how certain rates are calculated using more recent data, and increases funding for fiscal years 2026 through 2030.
Money References
- LIMITATION.—The Secretary may not require an entity to, or give priority to an entity that plans to, use the funds of a grant under this section for activities that are not specified in this subsection.”; (5) in subsection (i)(2), by inserting “, which shall include employment and earnings outcomes described in subclauses (I) and (III) of section 116(b)(2)(A)(i) of the Workforce Innovation and Opportunity Act (29 U.S.C. 3141(b)(2)(A)(i)) with respect to the participation of such individuals with a substance use disorder in programs and activities funded by the grant under this section” after “subsection (g)”; (6) in subsection (j)— (A) in paragraph (1), by inserting “for grants awarded prior to the date of enactment of the SUPPORT for Patients and Communities Reauthorization Act of 2025” after “grant period under this section”; and (B) in paragraph (2)— (i) in the matter preceding subparagraph (A), by striking “2 years after submitting the preliminary report required under paragraph (1)” and inserting “September 30, 2030”; and (ii) in subparagraph (A), by striking “(g)(3)” and inserting “(g)(1)(C)”; and (7) in subsection (k), by striking “$5,000,000 for each of fiscal years 2019 through 2023” and inserting “$12,000,000 for each of fiscal years 2026 through 2030”. (b) Reauthorization of the CAREER Act; Recovery Housing Pilot Program.— (1) IN GENERAL.—Section 8071 of the SUPPORT for Patients and Communities Act (42 U.S.C. 5301 note; Public Law 115–271) is amended— (A) by striking the section heading and inserting “CAREER Act; Recovery Housing Pilot Program”; (B) in subsection (a), by striking “through 2023” and inserting “through 2030”; (C) in subsection (b)— (i) in paragraph (1), by striking “not later than 60 days after the date of enactment of this Act” and inserting “not later than 60 days after the date of enactment of the SUPPORT for Patients and Communities Reauthorization Act of 2025”; and (ii) in paragraph (2)(B)(i)— (I) in subclause (I)— (aa) by striking “for calendar years 2013 through 2017”; and (bb) by inserting “for calendar years 2018 through 2022” after “rates of unemployment”; (II) in subclause (II)— (aa) by striking “for calendar years 2013 through 2017”; and (bb) by inserting “for calendar years 2018 through 2022” after “participation rates”; and (III) by striking subclause (III) and inserting the following: “(III) The highest age-adjusted average rates of drug overdose deaths for calendar years 2018 through 2022 based on data from the Centers for Disease Control and Prevention, including, if necessary, provisional data for calendar year 2022.”; and (D) in subsection (f), by striking “For the 2-year period following the date of enactment of this Act, the” and inserting “The”.
306. Addressing economic and workforce impacts of the opioid crisis Read Opens in new tab
Summary AI
The section updates the SUPPORT for Patients and Communities Act by extending the deadline from 2023 to 2030 for addressing the economic and workforce impacts of the opioid crisis.
401. Delivery of a controlled substance by a pharmacy to a prescribing practitioner Read Opens in new tab
Summary AI
The amendment to Section 309A(a) of the Controlled Substances Act allows for a pharmacy to deliver certain controlled substances, specifically those in schedule III, IV, or V, to a prescribing doctor. These substances can be used for treatments like injection or implantation for maintenance or detoxification, or when there's a plan to ensure safe use that includes health provider monitoring after use.
402. Required training for prescribers of controlled substances Read Opens in new tab
Summary AI
The section of the bill requires certain health organizations to be included in training programs for prescribers of controlled substances, such as the American Academy of Family Physicians and the Council on Podiatric Medical Education. These changes ensure a broader range of professional groups are involved in the education of prescribers, effective from December 29, 2022.